Core Laboratories Inc.

Informe acción NYSE:CLB

Capitalización de mercado: US$995.8m

Salud financiera de hoja de balance de Core Laboratories

Salud financiera controles de criterios 4/6

Core Laboratories tiene un patrimonio de accionistas total de $256.4M y una deuda total de $139.9M, lo que sitúa su ratio deuda-patrimonio en 54.5%. Sus activos y pasivos totales son $600.5M y $344.0M respectivamente. El BAIT de Core Laboratories es de $56.2M, por lo que su ratio de cobertura de intereses es de 4.2. Tiene efectivo e inversiones a corto plazo que ascienden a $21.5M.

Información clave

54.5%

Ratio deuda-patrimonio

US$139.87m

Deuda

Ratio de cobertura de intereses4.2x
EfectivoUS$21.47m
PatrimonioUS$256.42m
Total pasivoUS$344.05m
Activos totalesUS$600.47m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Core Laboratories (NYSE:CLB) Using Too Much Debt?

Nov 12
Is Core Laboratories (NYSE:CLB) Using Too Much Debt?

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?

Sep 19
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?

What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E

Aug 14
What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E

We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt

Jul 15
We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt

These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong

Jun 25
These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong

It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

May 02
It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Mar 26
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Mar 02
Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

Nov 09

Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Sep 08
Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up

Aug 16

Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

Jul 05
Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence

May 25
The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($235.2M) de CLB superan a sus pasivos a corto plazo ($94.9M).

Pasivo a largo plazo: Los activos a corto plazo ($235.2M) de CLB no cubren sus pasivos a largo plazo ($249.1M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de CLB (46.2%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de CLB ha pasado de 153.4% a 54.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de CLB está bien cubierta por el flujo de caja operativo (39.5%).

Cobertura de intereses: Los pagos de intereses de la deuda de CLB están bien cubiertos por el BAIT (4.2x cobertura).


Hoja de balance


Descubre empresas con salud financiera